Decision-making with uncertainty: The value of information

The Elgar Companion to Health Economics: Second Edition

Volumn , Issue , 2012, Pages 550-562

  Claxton, Karl ^a   Fenwick, Elisabeth ^b   Sculpher, Mark J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881863740     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (35)

1. Ades, A.E. (2003), 'A chain of evidence with mixed comparisons: models for multi-parameter evidence synthesis and consistency of evidence', Statistics in Medicine, 22, 2995-3016.
2. Ades, A.E., G. Lu and K. Claxton (2003), 'Expected value of sample information in medical decision modelling', Medical Decision Making, 24, 207-27.
3. Barton, G., A. Briggs and E. Fenwick (2008), 'Optimal cost-effectiveness decisions: the role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI)', Value in Health, 11, 886-97.
4. Black, W.C. (1990), 'The CE plane: a graphic representation of cost-effectiveness', Medical Decision Making, 10, 212-14.
5. Briggs, A.H., R. Goeree, G. Blackhouse and B.J. O'Brien (2002a), 'Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease', Medical Decision Making, 22, 290-308.
6. Briggs, A.H., B.J. O'Brien and G. Blackhouse (2002b), 'Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies', Annual Review of Public Health, 23, 377-401.
7. Burls, A., W. Clark, C. Preston, S. Bryan, A. Stewart, T. Jafferson et al. (2000), Zanamivir for the Treatment of Influenza in Adults: Supplement to the Assessment Report, London: National Institute for Health and Clinical Excellence, www.nice.org.
8. Claxton, K., L. Ginnelly, M. Sculpher, Z. Philips and S. Palmer (2004), 'A pilot study on the use of decision theory and value of information analysis as part of the National Health Service Health Technology Assessment Programme', Health Technology Assessment, 8 (31).
9. Claxton, K., P.J. Neuman, S.S. Araki and M.C. Weinstein (2001), 'The value of information: an application to a policy model of Alzheimer's disease', International Journal of Technology Assessment in Health Care, 17, 38-55.
10. Claxton, K. and J. Posnett (1996), 'An economic approach to clinical trial design and research priority-setting', Health Economics, 5, 513-24.
11. Conti, S. and K. Claxton (2009), 'Dimensions of design space: a decision theoretic approach to optimal research portfolio design', Medical Decision Making, 29, 643-60.
12. Critchfield, G.C., K.E. Willard and D.P. Connelly (1986), 'Probabilistic analysis of decision trees using Monte Carlo simulation', Medical Decision Making, 6, 85-92.
13. Doubilet, P., C.B. Begg, M.C. Weinstein, P. Braun and B.J. McNeill (1985), 'Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach', Medical Decision Making, 5, 157-77.
14. Eckermann, S. and A. Willan (2006), 'Expected value of information and decision making in HTA', Health Economics, 16, 195-209.
15. Fenwick, E., K. Claxton and M. Sculpher (2001), 'Representing uncertainty: the role of cost-effectiveness acceptability curves', Health Economics, 10, 779-89.
16. Fenwick, E., K. Claxton and M. Sculpher (2008), 'The value of implementation and the value of information: combined and uneven development', Medical Decision Making, 28, 21-32.
17. Fenwick, E., B.J. O'Brien and A. Briggs (2004), 'Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions', Health Economics, 13, 405-15.
18. Griffin, S., K. Claxton, S. Palmer and M. Sculpher (2011), 'Dangerous omissions: the consequences of ignoring decision uncertainty', Health Economics, 29, 212-24.
19. Griffin, S., N. Welton and K. Claxton (2010), 'Exploring the research decision space: the expected value of sequential research designs', Medical Decision Making, 30, 155-62.
20. Hjelmgren, J., F. Berggren and F. Andersson (2001), 'Health economic guidelines-similarities, differences and some implications', Value in Health, 4, 225-50.
21. Hoomans, T., E. Fenwick, S. Palmer and K. Claxton (2009), 'Value of information and value of implementation: application of an analytical framework to inform resource allocation decisions in Metastatic Hormone-Refractory Prostate Cancer', Value in Health, 12, 315-24.
22. Hunink, M., P. Glaziou, J. Siegel, J. Weeks, J. Pliskin, A. Elstein et al. (2001), Decision Making in Health and Medicine: Integrating Evidence and Values, Cambridge: Cambridge University Press.
23. McKenna, C. and K. Claxton (2011), 'Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis', Medical Decision Making, 31, 853-865.
24. National Institute for Clinical Excellence (NICE) (2004), Guide to the Methods of Technology Appraisal. London: NICE.
25. Palmer, S. and P.C. Smith (2000), 'Incorporating option values into the economic evaluation of health care technologies', Journal of Health Economics, 19, 755-66.
26. Philips, Z., K. Claxton and S. Palmer (2008), 'The half-life of truth? What are the appropriate time horizons for research decisions?', Medical Decision Making, 28, 287-99.
27. Pratt, J., H. Raiffa and R. Schlaiffer (1995), Statistical Decision Theory, Cambridge, MA: MIT Press.
28. Raiffa, H. and R. Schlaifer (1959), Probability and Statistics for Business Decisions, New York: McGraw-Hill.
29. Sculpher, M., K. Claxton and R. Akehurst (2005), 'It's just evaluation for decision making: recent developments in, and challenges for, cost-effectiveness research', in P.C. Smith, L. Ginnelly and M. Sculpher, Health Policy and Economics: Opportunities and Challenges, Maidenhead: Open University Press.
30. Spiegelhalter, D.J., K.R. Abrams and J.P. Myles (2004), Bayesian Approaches to Clinical Trials and Healthcare Evaluation, Chichester: Wiley.
31. Stinnett, A. and J. Mullahy (1998), 'Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analyses', MedicalDecision Making, 18, S68-S80.
32. Sutton, A.J. and K.R. Abrams (2001), 'Bayesian methods in meta-analysis and evidence synthesis', Statistical Methods in Medical Research, 10, 277-303.
33. Thompson, K.M. and J.S. Evans (1997), 'The value of improved national exposure information for perchlo-roethylene (perc): a case study for dry cleaners', Risk Analysis, 17, 253-71.
34. Van Hout, B.A., M.J. Al, G.S. Gordon and F.F.H. Rutten (1994), 'Costs, effects and c/e-ratios alongside a clinical trial', Health Economics, 3, 309-19.
35. Willan, A.R. and S. Eckermann (2010), 'Optimal clinical trial design using value of information methods with imperfect implementation', Health Economics, 19, 549-61.